Which drug overdoses can be treated with intravenous sodium bicarbonate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sodium Bicarbonate for Drug Overdoses

Intravenous sodium bicarbonate is primarily indicated for life-threatening cardiotoxicity from sodium channel blocker overdoses, most notably tricyclic/tetracyclic antidepressants, with reasonable use extending to other sodium channel blocking drugs including cocaine, flecainide, diphenhydramine, and local anesthetics causing wide-complex dysrhythmias. 1

Primary Indications (Class 1 Recommendation)

Tricyclic and Tetracyclic Antidepressants (TCAs)

  • Strongest evidence base for sodium bicarbonate use 1
  • Common TCAs include: amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, maprotiline, nortriptyline, protriptyline, and trimipramine 1
  • Administer for life-threatening cardiotoxicity manifesting as:
    • QRS prolongation (typically >100-120 milliseconds)
    • Hypotension
    • Ventricular dysrhythmias
    • Cardiovascular collapse

Secondary Indications (Class 2a - Reasonable to Use)

Other Sodium Channel Blockers

It is reasonable to use sodium bicarbonate for life-threatening cardiotoxicity from: 1

  • Cocaine (specifically mentioned in guidelines)
  • Carbamazepine
  • Diphenhydramine 2
  • Flecainide 3
  • Propafenone
  • Quinidine
  • Quinine
  • Lamotrigine
  • Lacosamide
  • Venlafaxine
  • Topiramate
  • Zonisamide
  • Thioridazine
  • Taxus species (yew)

Atypical Antipsychotics

  • Quetiapine and trazodone overdoses can cause sodium channel blockade responsive to sodium bicarbonate 4

Local Anesthetics

  • Class 2a recommendation for wide-complex tachycardia associated with local anesthetic toxicity 1
  • Note: Intravenous lipid emulsion is the primary treatment for local anesthetic systemic toxicity (LAST), but sodium bicarbonate serves as adjunctive therapy

SSRIs (Limited Evidence)

  • Citalopram overdose with junctional bradycardia has responded to sodium bicarbonate 5
  • This represents emerging evidence beyond traditional indications

Dosing and Administration

Adult Dosing

  • Hypertonic solution: 1000 mEq/L (typically 8.4% sodium bicarbonate) 1
  • Administer as bolus doses titrated to:
    • Resolution of hypotension
    • QRS narrowing
    • Correction of dysrhythmias

Pediatric Dosing

  • Hypertonic solution: 500 mEq/L 1

Mechanism

Sodium bicarbonate works through dual mechanisms:

  1. Sodium loading - overcomes sodium channel blockade
  2. Alkalinization - correction of acidemia or induction of alkalemia
  3. These effects are additive 1

Critical Monitoring Parameters

Safety Thresholds

Avoid extremes to prevent iatrogenic harm: 1

  • Serum sodium: do not exceed 150-155 mEq/L
  • Serum pH: do not exceed 7.50-7.55
  • Monitor and treat hypokalemia - sodium bicarbonate therapy commonly causes potassium depletion

ECG Monitoring

Look for characteristic changes that precede ventricular dysrhythmias:

  • QRS prolongation (intraventricular conduction delay)
  • Terminal rightward axis deviation (best seen in lead aVR) 1

QRS Duration Thresholds

  • Contemporary practice uses QRS ≥120 milliseconds as threshold for sodium bicarbonate 6
  • This represents an increase from historical threshold of 100 milliseconds
  • Adjust threshold upward in patients with baseline QRS prolongation 6

Important Clinical Caveats

Drug-Specific Considerations

  • Bupropion: 43% of toxicologists are less likely to recommend sodium bicarbonate despite sodium channel blocking properties 6
  • Chloroquine/hydroxychloroquine: Treatment is outside the scope of standard sodium channel blocker protocols 1

Maintenance Therapy

The optimal approach after initial boluses is unsettled 1:

  • Option 1: Continuous infusion
  • Option 2: Monitor and give additional boluses as needed

Treatment Failures

  • Treatment failures are reported even with appropriate sodium bicarbonate use 1
  • Have backup plan ready: VA-ECMO for refractory cardiogenic shock (Class 2a recommendation) 1

Second-Line Therapies

If sodium bicarbonate fails or is insufficient:

  1. Hypertonic saline (for sodium loading without alkalinization)
  2. Lidocaine (Class Ib antidysrhythmic - competes at sodium channel) 1
  3. Intravenous lipid emulsion (Class 2b - may be reasonable for refractory cases) 1
  4. VA-ECMO (for refractory shock)

What Sodium Bicarbonate Does NOT Treat

Sodium bicarbonate is NOT indicated for:

  • Routine cardiac arrest without specific sodium channel blocker toxicity 1
  • General metabolic acidosis in poisoning (unless specifically from sodium channel blockers)
  • Opioid overdose
  • Beta-blocker or calcium channel blocker toxicity
  • Digoxin toxicity
  • Organophosphate poisoning
  • Sympathomimetic toxicity without sodium channel blockade

The evidence strongly supports sodium bicarbonate as first-line antidotal therapy specifically for sodium channel blocking drug poisonings, with the mechanism targeting the unique cardiotoxicity profile of these agents rather than serving as general supportive care.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.